- Investing.com
तुलना करने के लिए मीट्रिक्स | DYAI | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधDYAIपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −3.9x | −1.7x | −0.5x | |
PEG अनुपात | 0.28 | −0.18 | 0.00 | |
क़ीमत/बुक | 23.2x | 2.6x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 9.3x | 60.6x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 76.4% | 48.8% | |
उचित मूल्य अपसाइड | अनलॉक करें | 1.4% | 6.9% | अनलॉक करें |
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.